Hormones
Lab International Announces Positive Results From Its Growth Hormone Releasing Hormone (ghrh) Phase Ii Trial
Published in Medicine and Law Weekly, August 3rd, 2007
LAB International Inc. (TSX: LAB, Frankfurt: LD9.F, XETRA: LD9.DE) ("LAB"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced positive interim results from its pilot GHRH Phase II study. Within 4 weeks of treatment, LAB GHRH induced a highly significant stimulation of endogenous growth hormone (GH) secretion and a marked increase of circulating insulin-like growth factor (IGF-1) as compared to placebo in patients with chronic kidney disease. These endocrine effects were associated with a significant increase in Fat Free Mass (FFM) and concomitant reduction in Fat Mass (FM) when measured by DEXA scan. While stable isotope studies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Anemia
Reports outline anemia in children research from Johns Hopkins University, Department of International Health - Chromatography
New findings from Hunan University in the area of chromatography published - Clinical Trial Research
Studies from Royal University have provided new information about clinical trial research in children - Criminology
Researchers from University of Oxford describe findings in criminology - Drug Abuse
Scientists at Taipei Medical University discuss research in drug abuse - Escherichia coli
Recent findings in escherichia coli described by L.S.S. Barros and colleagues - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
